Request Registration Code

Terms of Service

All messages posted at this site express the views of the author, and do not necessarily reflect the views of the owners and administrators of this site.

By registering at this site you agree not to post any messages that are obscene, vulgar, slanderous, hateful, threatening, or that violate any laws. We will permanently ban all users who do so.

We reserve the right to remove, edit, or move any messages for any reason.

  I agree to the terms of service


The CI Check-In App is now available

Tuesday, 24 November 2015 by System Administrator


The Cryonics Institute's Standby Check-In app for Android devices is now available on Google Play for 99¢.

Why Businesses Embrace Machine Learning

Friday, 6 November 2015 by System Administrator

Fotolia 73920708 xs

Why Businesses Embrace Machine Learning [Excerpt]
The best algorithms determine who wins and loses in a digital economy that thrives on steering the consumer toward an opportune click
By Pedro Domingos | October 29, 2015

Why is Google worth so much more than Yahoo? They both make their money from showing ads on the web, and they’re both top destinations. Both use auctions to sell ads and machine learning to predict how likely a user is to click on an ad (the higher the probability, the more valuable the ad). But Google’s learning algorithms are much better than Yahoo’s. This is not the only reason for the difference in their market caps, of course, but it’s a big one. Every predicted click that doesn’t happen is a wasted opportunity for the advertiser and lost revenue for the website. With Google’s annual revenue of $50 billion, every 1 percent improvement in click prediction potentially means another half billion dollars in the bank, every year, for the company. No wonder Google is a big fan of machine learning, and Yahoo and others are trying hard to catch up.

Human Age-Reversal Research

Friday, 6 November 2015 by System Administrator

Fotolia 61719252 xs

Human Age-Reversal Research

By William Falloon

For the first time in medical history, human studies are being designed for the purpose of inducing meaningful reversal of pathological aging processes. Said differently, these clinical trials aim to alter older humans so that they function as much younger individuals.

Even modest success of these studies will result in a paradigm shift that will impart enormous societal benefits, such as sparing Medicare from insolvency.

If I were asked even a few years ago if significant human age-reversal research was feasible, I would have said no. Virtually all attempts to slow aging are conducted in the laboratory setting, far removed from delivery to elderly people who have only a few years of life remaining.